首页> 外文期刊>Journal of biopharmaceutical statistics >Discussion of the 'White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs'
【24h】

Discussion of the 'White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs'

机译:Discussion of the "White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs"

获取原文
获取原文并翻译 | 示例
           

摘要

First, I would like to thank the authors for putting together this important survey paper. They have covered a wide range of methods that are applied in dose ranging studies, with the emphasis on model-based techniques, from Bayesian modeling to multiple comparison-modeling approach to model-based optimal designs to nonparametric estimation techniques. These methods are of personal interest to me and I expect that the paper will generate a lot of interest from the readers of the journal. Still there is one specific area which, in my opinion, should have been covered in more detail - namely, what the authors call "D-optimal response-adaptive", or "Dopt approach". I understand that the authors address a variety of methods, and the goals of this paper are different from providing a comprehensive review of each method. However a complete lack of references on optimal model-based designs seems rather strange.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号